Brain-Computer Interface Stocks Rebound Intraday; Xiangyu Medical Surges Over 15%

Brain-computer interface (BCI) concept stocks staged an intraday rebound. Xiangyu Medical rose more than 15%, while Aipeng Medical, Sanbo Brain Hospital, Chuangxin Medical, Yingnuote, and Meihao Medical each gained over 5%, signaling a brief pickup in sector trading activity.

The move is a typical market flash with limited standalone information, but its timing merits attention. In mid-October, the Ministry of Industry and Information Technology (MIIT) presented humanoid robot industry progress at an October 19 press conference. The Ministry of Commerce and nine other departments issued a document to promote embodied intelligence applications in the commerce sector. Wuhan also reported clinical cases across all three BCI technical routes.

These policy and industry disclosures were concentrated in the same period. The BCI concept's rebound at this point appears linked to that dense release of updates, as market attention to the commercialization progress of related technologies edged higher. The gainers span medical device and clinical service names, suggesting investors are tracking both equipment and application-side developments. While the headline itself carries modest informational value, the confluence of policy signals and local clinical milestones provides a broader context for the move. The rebound reflects short-term sentiment rather than a fundamental shift.